Gewählte Publikation:
SHR
Neuro
Krebs
Kardio
Lipid
Stoffw
Microb
Worel, N; Greinix, HT; Leitner, G; Mitterbauer, M; Rabitsch, W; Rosenmayr, A; Höcker, P; Kalhs, P.
ABO-incompatible allogeneic hematopoietic stem cell transplantation following reduced-intensity conditioning: close association with transplant-associated microangiopathy.
Transfus Apher Sci. 2007; 36(3): 297-304.
Doi: 10.1016/j.transci.2007.03.004
Web of Science
PubMed
FullText
FullText_MUG
- Co-Autor*innen der Med Uni Graz
-
Greinix Hildegard
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
-
Transplant-associated microangiopathy (TAM) is a severe complication following allogeneic hematopoietic stem cell transplantation (HSCT) even after reduced-intensity conditioning (RIC). Data on 112 patients following RIC were analyzed with respect to TAM according to the ASBMT and risk factors, response to well-defined therapy and outcome were determined. TAM occurred in 11 of 112 patients. Univariate analysis determined acute graft-versus-host disease and ABO-incompatibility as risk factors for TAM. Treatment consisted of withdrawal of calcineurin inhibitors and plasma exchange (PE). Response to PE was 64%. PE seems to be an effective therapeutic option that should be assessed in larger patient cohorts.
- Find related publications in this database (using NLM MeSH Indexing)
-
ABO Blood-Group System - immunology
-
Adolescent -
-
Adult -
-
Aged -
-
Blood Group Incompatibility - complications
-
Female -
-
Graft vs Host Disease -
-
Hematopoietic Stem Cell Transplantation - adverse effects Hematopoietic Stem Cell Transplantation - methods
-
Humans -
-
Male -
-
Microcirculation -
-
Microvessels - pathology
-
Middle Aged -
-
Peripheral Vascular Diseases - etiology Peripheral Vascular Diseases - therapy
-
Plasma Exchange -
-
Risk Factors -
-
Transplantation Conditioning - methods
-
Transplantation, Homologous -
-
Treatment Outcome -
-
Young Adult -